AOXING PHARMACEUTICAL COMPANY, INC. - FORM 10-K - EX-23.1 - CONSENT OF BDO CHINA DAHUA CPA CO., LTD. - October 15, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AOXING PHARMACEUTICAL COMPANY, INC.Financial_Report.xls
EX-32.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh321.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh312.htm
EX-23.2 - CONSENT OF PARITZ & COMPANY, P.A. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh232.htm
EX-32.2 - CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh311.htm
EX-21.1 - LIST OF SUBSIDIARIES - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh211.htm
10-K - AOXING PHARMACEUTICAL COMPANY, INC. 10K 2012-06-30 - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10k.htm
Exhibit 23.1

 
Consent of Independent Registered Public Accounting Firm
 

 
The Board of Director and Stockholders
Aoxing Pharmaceutical Company, Inc.

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-177641) of Aoxing Pharmaceutical Company, Inc. of our report dated October 15, 2012, relating to the consolidated financial statements of Aoxing Pharmaceutical Company, Inc. which appear in this Annual Report on Form 10-K.

/s/ BDO China Dahua CPA Co., Ltd.

Shenzhen, People’s Republic of China
October 15, 2012

AOXING PHARMACEUTICAL COMPANY, INC. Reports